Arkolith/Insider Trading/ORIC/Form 4

Piscitelli Dominic

Chief Financial OfficerOric Pharmaceuticals, Inc. (ORIC) · full profile →Form 4 · filed Feb 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$703K
Net Open-Market Flow
-$703K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2026Sell(S)52K$13.51$703K68K
Feb 24, 2026Option exercise(M)52K$4.36$227K120K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 24, 2026Option exercise(M)52K—$0145K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001695028-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML